SCHEMBL7201167

SCHEMBL7201167

Cc1ccc(C(=O)Nc2ccc(N(CCn3cccn3)C(=O)O)cc2)c(N(C)C)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRB P10828 1/20 0.40
KMT2A Q03164 5/20 0.39
MEN1 O00255 2/20 0.39
HSD17B10 Q99714 2/20 0.38
ALOX15 P16050 1/20 0.38
RAB9A P51151 5/20 0.38
NPC1 O15118 3/20 0.38
HIF1A Q16665 1/20 0.38
ALDH1A1 P00352 5/20 0.37
MAPT P10636 3/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
PDK1 Q15118 1/20 0.37
LMNA P02545 1/20 0.36
MAPK1 P28482 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6650061 0.90 SMN1; SMN2 (0.42) THRBKMT2AMEN1HSD17B10ALOX15
SCHEMBL6643832 0.90 NAMPT (0.42) THRBKMT2AHSD17B10ALOX15RAB9A
SCHEMBL6642961 0.89 THRB (0.38) THRBKMT2AHSD17B10ALOX15RAB9A
SCHEMBL6647472 0.89 THRB (0.43) THRBKMT2AMEN1RAB9ANPC1
SCHEMBL6645501 0.88 LMNA (0.47) THRBHIF1AMAPTLMNAPTGDR2
SCHEMBL6646119 0.87 THRB (0.40) THRBKMT2AMEN1HSD17B10ALOX15
SCHEMBL6649808 0.85 THRB (0.43) THRBKMT2AMEN1HSD17B10ALOX15
SCHEMBL7201171 0.83 SCD (0.43) KMT2ARAB9AALDH1A1MAPTTDP1
SCHEMBL6644554 0.82 ALDH1A1 (0.45) THRBKMT2AHSD17B10ALOX15RAB9A
SCHEMBL6644406 0.82 THRB (0.53) THRBHSD17B10RAB9ANPC1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004039795-A2 AMIDE COMPOUNDS FOR THE TREATMENT OF HYPERLIPIDEMIA FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-05-13 WO disclosed